SCHEMBL20567994

SCHEMBL20567994

CCC(I)c1c[nH]c2c(=O)[nH]cnc12

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PNP P00491 15/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22907451 0.79 PNP (0.55) PNP
SCHEMBL13691975 0.75 PNP (0.62) PNP
SCHEMBL6643757 0.70 PNP (0.56) PNP
SCHEMBL15628196 0.70 PDPK1 (0.55) PNP
SCHEMBL1946264 0.69 PNP (1.00) PNP
SCHEMBL1945120 0.69 PNP (1.00) PNP
SCHEMBL1945118 0.69 PNP (1.00) PNP
Hydrochloric Acid SCHEMBL1946553 0.68 PNP (0.97) PNP
Hydrochloric Acid SCHEMBL1946550 0.68 PNP (0.97) PNP
SCHEMBL4736800 0.68 PNP (0.50) PNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630769-A1 NOVEL DUAL MODE OF ACTION SOLUBLE GUANYLATE CYCLASE ACTIVATORS AND PHOSPHODIESTERASE INHIBITORS AND USES THEREOF Topadur Pharma AG (CH) 2020-04-08 EP disclosed
WO-2018215433-A1 NOVEL DUAL MODE OF ACTION SOLUBLE GUANYLATE CYCLASE ACTIVATORS AND PHOSPHODIESTERASE INHIBITORS AND USES THEREOF TOPADUR PHARMA AG (CH) 2018-11-29 WO disclosed